Background And Objectives: Multiple tools exist for assessing the methodological quality of diagnosis and prognosis research. It can be challenging to decide on when to use which tool. We aimed to provide an overview of existing methodological quality assessment (QA) tools for diagnosis and prognosis studies, highlight the overlap and differences among these tools, and to provide guidance for choosing the appropriate tool.
Study Design And Setting: We performed a methodological review of tools designed for assessing risk of bias, applicability, or other aspects related to methodological quality in studies investigating tests/factors/markers/models for classifying or predicting a current (diagnosis) and/or future (prognosis) health state. Tools focusing exclusively on causal research or on reporting quality were excluded. Guidance was subsequently developed to assist in choosing an appropriate QA tool.
Results: We identified 14 QA tools, eight of which were developed for assessment of diagnosis studies, four for prognosis studies, and two addressing both. We propose a set of five questions to help guide the process of choosing a QA tool based on the purpose or question of the user: whether the focus is on (1) diagnosis, prognosis, or another domain; (2) a prediction model vs a test/factor/marker; (3) evaluating simply the performance of a test/factor/marker vs assessing its added value over other variables; (4) comparing two or more tests/factors/markers/models; and (5) whether the user aims to assess only risk of bias or also other quality aspects.
Conclusion: Existing QA tools for appraising diagnosis and prognosis studies vary in purpose, scope, and contents. Our guidance may help researchers, systematic reviewers, health policy makers, and guideline developers in specifying their purpose and question to select the most appropriate QA tool for their assessment.
Plain Language Summary: Methodological quality assessment (QA) tools provide a set of criteria to evaluate how well a medical study was done and how trustworthy its results are. To accurately assess a study's quality, it is important to use a QA tool that matches the type of medical study. However, with many QA tools available for different study types, choosing the right one can be challenging, especially for diagnosis and prognosis studies (ie, studies that evaluate tests, factors, markers, and models used for diagnosis and prognosis). To assist in selecting the best QA tools for diagnostic and prognostic studies, we created an overview of available tools and practical tips for choosing the most appropriate one. After searching online databases and consulting experts in the field, we identified 14 QA tools specific to diagnostic and prognostic studies. Additionally, we developed five key questions to guide users in choosing the best tool for their study. While the 14 QA tools differ in their focus and content, our guidance simplifies the process of choosing the right tool and helps users refine their research question.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jclinepi.2024.111609 | DOI Listing |
JAMA Netw Open
January 2025
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Importance: During buprenorphine treatment for opioid use disorder (OUD), risk factors for opioid relapse or treatment dropout include comorbid substance use disorder, anxiety, or residual opioid craving. There is a need for a well-powered trial to evaluate virtually delivered groups, including both mindfulness and evidence-based approaches, to address these comorbidities during buprenorphine treatment.
Objective: To compare the effects of the Mindful Recovery Opioid Use Disorder Care Continuum (M-ROCC) vs active control among adults receiving buprenorphine for OUD.
Transl Vis Sci Technol
January 2025
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Purpose: This study investigates the association between visual function and retinal vasculature metrics, particularly perfusion capacity (PC), in eyes with idiopathic epiretinal membrane (iERM), using optical coherence tomography angiography (OCTA).
Methods: This retrospective study includes 30 eyes from 30 iERM patients who had surgery, with a three-month follow-up period. In addition, 28 eyes from 28 healthy individuals served as a control group.
Background: Molnupiravir (MOV) is an orally bioavailable ribonucleoside with antiviral activity against all tested SARS-CoV-2 variants. We describe the demographic, clinical, and treatment characteristics of non-hospitalized Danish patients treated with MOV and their clinical outcomes following MOV initiation.
Method: Among all adults (>18 years) who received MOV between 16 December 2021 and 30 April 2022 in an outpatient setting in Denmark, we summarized their demographic and clinical characteristics at baseline and post-MOV outcomes using descriptive statistics.
Neurosurg Rev
January 2025
Department of neurosurgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Epilepsy is a common neurological disease that is treated with medications; however, patients with drug-resistant epilepsy, commonly intractable temporal lobe epilepsy, tend to have better control with surgical treatment. While the mainstay of surgical treatment is anterior temporal lobectomy, it carries risk of potential adverse effects hence minimally invasive techniques are now being used as an alternative to open surgery. This systematic review and meta-analysis compare the efficacy and safety of three of the most used techniques: laser interstitial thermal therapy (LITT), radiofrequency ablation (RFA) and stereotactic radiosurgery (SRS).
View Article and Find Full Text PDFJ Gastrointest Cancer
January 2025
Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Pancreatic ductal adenocarcinoma is a devastating disease which is associated with an increase in cancer-related death in the USA. The minority of patients are cured by surgery alone and typically require adjuvant chemotherapy in order to improve clinical outcomes. Circulating tumor DNA (ctDNA) is an emerging technology whereby microscopic levels of minimal residual disease (MRD) can be detected in the bloodstream.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!